Articles Published in 2009

Kendle 3Q Revenues, Net Income Slide

Thursday, November 5, 2009 09:16 AM

Kendle, a global contract research organization, reported third quarter net income slipped to $8.8 million or $0.59 per diluted share for the third quarter of 2009, compared with net income of $9.4 million or $0.62 per diluted share for the third quarter of 2008.  

More... »

Omnicare Clinical Research Opens Seoul Office

Thursday, November 5, 2009 08:33 AM

Pennsylvania-based Omnicare Clinical Research, a global contract research organization (CRO), has opened an office in Seoul, South Korea.

More... »

Quintiles in Alliances with AstraZeneca, Eisai

Wednesday, November 4, 2009 07:21 AM

Quintiles has entered into a strategic alliance with AstraZeneca. The contract research organization (CRO)-clinical pharmacology alliance with AstraZeneca was formed to deliver the sponsor’s clinical pharmacology studies across multiple therapy areas and around the globe.

More... »

Schulman Associates IRB Expands into Canada

Tuesday, November 3, 2009 08:31 AM

Cincinnati-based Schulman Associates IRB has expanded its institutional review board (IRB) services into Canada. For North American studies, which are conducted in both the U.S. and Canada, Canadian and U.S. board members will review the research together to maintain consistency.

More... »

CenterWatch Monthly November 2009

Monday, November 2, 2009 06:14 AM

How Investigative Sites Are Making it in Tough Times

More... »

PPD to Buy China-Based Excel PharmaStudies, Spin Off Compound Partnering

Monday, November 2, 2009 06:09 AM

Signaling a major strategic shift, PPD is focusing on Asia-Pacific—China in particular. The company has made a big move in the region by entering into an agreement to acquire Excel PharmaStudies, one of the largest contract research organizations (CROs) in China, which will provide PPD additional capacity in China’s rapidly growing pharmaceutical market. PPD also plans to spin off its compound partnering business from its core CRO work and invest $100 million in Celtic Therapeutics.

More... »

Phase Forward Q3 Revenues Jump 24%, Earnings Down by Half

Friday, October 30, 2009 09:11 AM

Waltham, Mass-based Phase Forward, a provider of data management solutions for clinical trials and drug safety, reported third quarter revenues jumped 24% to $53.1 million, compared with the third quarter of 2008, but earnings were cut in half.

More... »

PRA International Opens Milan Office

Friday, October 30, 2009 07:30 AM

Raleigh, N.C.-based PRA International, a CRO, has opened a new office in Milan, Italy. PRA has operated in Italy since 2003 with home-based PRA staff.

More... »

Phase Forward Provides Free Download for CDISC Adopters

Thursday, October 29, 2009 09:04 AM

Phase Forward, a provider of data management solutions for clinical trials and drug safety, released its DefineValidator tool, Release 1.0, as a free download for Clinical Data Interchange Standards Consortium (CDISC) adopters.

More... »

Laboratorio Hidalgo Expands Central Lab in Buenos Aires

Wednesday, October 28, 2009 09:59 AM

Laboratorio Hidalgo, a central laboratory in Buenos Aires, Argentina, has increased its capacity for its clinical trials division with a new facility five minutes from its headquarters and laboratory.

More... »

CenterWatch Data Library



Browse by:


December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs